TVG Marketing Model TVG Advantages News and Events Recent Articles & Presentations Our Heritage Return Home


Join TVG at the World Orphan Drug Congress

Published: Apr 18, 2016

April 20-22, 2016  The World Orphan Drug Conference in Washington, DC

Join TVG at this conference responsible for bringing together pharmaceutical and biotech, KOLs, patient advocacy groups, academia,investors and key industry leaders from all over the world. Whether you are looking to develop, commercialize or market Orphan Drugs, you will meet unique challenges requiring different, and sometimes creative approaches to be successful. 

Although individual Rare Diseases occur in less than 200,000 patients in the United States, there are over 300 million people in the US with a Rare Disease. While there are over 7,000 Rare Diseases, drugs have been developed to treat only 5% of those conditions.. 

Orphan drugs can be used to treat non-rare diseases and conditions leading to profitability generated through other indications and off label usage.  Although patient populations for each disease in every market are small, if the drug gains approval across a number of indications, the manufacturer can develop additional revenue streams. As a result, there are some Orphan Drugs that have achieved blockbuster status, and Orphan Drug designation being sought by some blockbuster drugs.